Critical-to-Quality (CtQ) is a measurable product or process characteristic that must meet a defined specification to satisfy patient safety, performance, or regulatory requirements. In medical device development, CtQs translate user needs and risk controls into specific, verifiable parameters that engineering and manufacturing teams design, monitor, and control throughout the product lifecycle.
What is Critical-to-Quality (CtQ)?
CtQ comes from Six Sigma and design for Six Sigma (DFSS), where it names the output characteristic a customer or patient actually cares about. A CtQ tree breaks a broad need, for example “the infusion pump delivers the right dose,” into concrete measurable targets such as flow-rate accuracy, occlusion alarm response time, and battery runtime.
In a regulated device program, CtQs sit at the junction of design controls and process controls. They begin as design inputs derived from user needs and risk analysis, then flow into design outputs, drawings, and specifications. On the manufacturing side, the same characteristics become the parameters a validated process has to hold, batch after batch.
Why Critical-to-Quality (CtQ) matters in medical device development
A missed CtQ is rarely just a scrap cost. When a characteristic that affects safety or efficacy drifts out of specification, the result can be a field failure, a complaint, or a recall. Regulators expect manufacturers to know which characteristics matter most and to prove they stay in control.
Getting CtQs right early also protects the schedule and budget. Teams that define the vital few characteristics up front can focus verification, inspection, and validation effort where it changes patient outcomes, instead of testing everything with equal weight. The FDA’s CDRH ran a Critical to Quality pilot with MDIC and industry to sharpen exactly this focus during premarket review.
How Critical-to-Quality (CtQ) works
CtQ management is a chain that runs from need to controlled parameter. A typical flow:
- Capture user needs and intended use, then derive design inputs.
- Run risk analysis under ISO 14971:2019 to find characteristics tied to harm.
- Translate those into measurable CtQs with limits and tolerances, often through a CtQ tree or quality function deployment.
- Decide, for each CtQ, whether it can be verified by inspection or must be assured through process validation.
- Set up controls: inspection, statistical process control, or a validated process with capability targets such as Cpk of 1.33 or higher.
The verify-or-validate decision is the hinge. If a characteristic can be measured on the finished device, such as the length of a bone screw, it can be verified directly. Where measurement would destroy the device or the outcome cannot be fully checked afterward, the process itself must be validated. That rule sits in ISO 13485:2016 clause 7.5.6, incorporated into US requirements through the FDA Quality Management System Regulation (QMSR), 21 CFR Part 820, effective February 2, 2026. The design controls that generate CtQs map to ISO 13485 clause 7.3.
Common challenges and best practices
The most common mistake is calling almost everything critical. When a specification lists dozens of “critical” dimensions, teams lose the ability to prioritize, and real risks hide in the noise. Good practice ties each CtQ back to a specific hazard or design input, so criticality is justified rather than assumed.
Two more failure patterns show up in audits. First, CtQs defined in design never reach the manufacturing control plan, so the shop floor monitors different parameters than engineering intended. Second, acceptance limits get set without capability data, and production then cannot meet them. Strong programs link design outputs, PFMEA, and the control plan into one traceable thread, and they confirm process capability before locking limits.
How SJML helps with Critical-to-Quality (CtQ)
SJML works as an end-to-end medical device CDMO, so CtQ definition and control stay connected from design through production. Engineering teams derive design inputs, run ISO 14971 risk management, and set measurable characteristics during verification and design transfer. On the manufacturing side, PFMEA, DfX reviews, and process validation (IQ, OQ, PQ) turn those characteristics into controlled, traceable parameters, supported by SPC and inspection in ISO Class 7 and 8 cleanroom and PCBA environments. Change control keeps CtQs aligned as the product matures.
Talk to SJML’s engineering team →
Frequently asked questions
The terms overlap heavily. CtQ comes from Six Sigma and describes any measurable characteristic that must meet a specification. Critical quality attribute (CQA) comes from Quality by Design and pharmaceutical practice, referring to a property that must stay within a limit to ensure product quality. In device work, both point to the vital characteristics a process must control.
A CtQ is any characteristic that must meet a specification to satisfy quality or compliance. A Critical to Function (CTF) characteristic is the subset that directly drives the device’s intended performance. CTFs are usually identified through critical parameter management, then linked to specific process controls. Every CTF is a CtQ, but not every CtQ affects function.
It depends on whether the characteristic can be measured on the finished device. If it can be measured, such as a dimension checked with calipers, it can be verified by inspection. If checking would destroy the device or the result cannot be fully confirmed afterward, the process must be validated. ISO 13485:2016 clause 7.5.6 sets this expectation.
No single standard defines the term, but several govern how CtQs are handled. Design controls under ISO 13485:2016 clause 7.3 generate them, ISO 14971:2019 ties them to risk, and process validation under clause 7.5.6 assures the ones that cannot be verified. In the US, these apply through the FDA QMSR, 21 CFR Part 820.
Related terms
- Design Verification
- Process Validation (IQ OQ PQ)
- Design Controls
- PFMEA
- Critical Quality Attribute (CQA)
